Federal Register / Vol. 62, No. 192 / Friday, October 3, 1997 / Notices 51875

Open on: February 17, 1998, 8:00 a.m. to

10:00 a.m. Closed for Remainder of Meeting.

Name of SEP: Physician Assistants Peer

Review Group.

Date and Time: February 23–26, 1998, 8:00

a.m. to 6:00 p.m.

Place: Holiday Inn Silver Spring, 8777

Georgia Avenue, Silver Spring, Maryland

20910.

Open on: February 23, 1998, 8:00 a.m. to

10:00 a.m. Closed for Remainder of Meeting.

Name of SEP: Geriatric Education Centers

Review Group.

Date and Time: March 2–5, 1998, 8:00 a.m.

to 6:00 p.m.

Place: Holiday Inn Silver Spring, 8777

Georgia Avenue, Silver Spring, Maryland

20910.

Open on: March 2, 1998, 8:00 a.m. to 10:00

a.m. Closed for Remainder of Meeting.

Name of SEP: Nurse Practitioner/Nurse

Midwifery Review Group.

Date and Time: March 9–12, 1998, 8:00

a.m. to 6:00 p.m.

Place: Holiday Inn Silver Spring, 8777

Georgia Avenue, Silver Spring, Maryland

20910.

Open on: March 9, 1998, 8:00 a.m. to 10:00

a.m. Closed for Remainder of Meeting.

Name of SEP: Basic AHEC Review Group

Date and Time: March 16–18, 1998, 8:00

a.m. to 6:00 p.m.

Place: Holiday Inn Silver Spring, 8777

Georgia Avenue, Silver Spring, Maryland

20910.

Open on: March 16, 1998, 8:00 a.m. to

10:00 a.m. Closed for Remainder of Meeting.

Name of SEP: Model AHEC Review Group.

Date and Time: March 16–18, 1998, 8:00

a.m. to 6:00 p.m.

Place: Holiday Inn Silver Spring, 8777

Georgia Avenue Silver Spring, Maryland

20910.

Open on: March 16, 1998, 8:00 a.m. to

10:00 a.m. Closed for Remainder of Meeting.

Name of SEP: Nursing Special Projects

Review Group.

Date and Time: March 23–26, 1998, 8:00

a.m. to 6:00 p.m.

Place: Holiday Inn Silver Spring, 8777

Georgia Avenue, Silver Spring, Maryland

20910.

Open on: March 23, 1998, 8:00 a.m. to

10:00 a.m. Closed for Remainder of Meeting.

Name of SEP: Advanced Nurse Education/

Nurse Anesthetist Review Group.

Date and Time: March 30–April 1, 1998,

8:00 a.m. to 6:00 p.m.

Place: Holiday Inn Silver Spring, 8777

Georgia Avenue Silver Spring, Maryland

20910.

Open on: March 30, 1998, 8:00 a.m. to

10:00 a.m. Closed for Remainder of Meeting.

Name of SEP: Allied Health Project Grants

Review Group

Date and Time: April 20–24, 1998, 8:00

a.m. to 6:00 p.m.

Place: Holiday Inn Silver Spring, 8777

Georgia Avenue, Silver Spring, Maryland

20910.

Open on: April 20, 1998, 8:00 a.m. to 10:00

a.m. Closed for Remainder of Meeting.

Name of SEP: Health Career Opportunity/

Minority Faculty Fellowship Review Group.

Date and Time: April 20–24, 1998, 8:00

a.m. to 6:00 p.m.

Place: Holiday Inn Silver Spring, 8777

Georgia Avenue Silver Spring, Maryland

20910.

Open on: April 20, 1998, 8:00 a.m. to 10:00

a.m. Closed for Remainder of Meeting.

Name of SEP: Health Career Opportunity

Review Group.

Date and Time: April 27–30, 1998, 8:00

a.m. to 6:00 p.m.

Place: Holiday Inn Silver Spring, 8777

Georgia Avenue, Silver Spring, Maryland

20910.

Open on: April 27, 1998, 8:00 a.m. to 10:00

a.m. Closed for Remainder of Meeting.

Name of SEP: Departments of Family

Medicine Peer Review Group.

Date and Time: May 18–21, 1998, 8:00 a.m.

to 6:00 p.m.

Place: Holiday Inn Silver Spring, 8777

Georgia Avenue, Silver Spring, Maryland

20910.

Open on: May 18, 1997, 8:00 a.m. to 10:00

a.m. Closed for Remainder of Meeting.

Purpose: The Health Professions and Nurse

Education Special Emphasis Panel shall

advise the Director of the Bureau of Health

Professions on the technical merit of grants

to improve the training, distribution,

utilization, and quality of personnel required

to staff the Nation’s health care delivery

system.

Agenda: The open portion of each meeting

will cover welcome and opening remarks,

financial management and legislative

implementation updates, and overview of the

review process. The meetings will be closed

after 10:00 a.m. on the first day of each

meeting until adjournment for the review of

grant applications. The closing is in

accordance with the provision set forth in

section 552b(c)(6), Title 5 U.S. Code, and the

Determination by the Acting Associate

Administrator for Management and Program

Support, Health Resources and Services

Administration, pursuant to Pub.L. 92–463.

Anyone wishing to obtain a roster of

members or other relevant information

should write or contact Mrs. Sherry Whipple,

Program Analyst, Peer Review Branch,

Parklawn Building, Room 8C–23, 5600

Fishers Lane, Rockville, Maryland 20857,

telephone (301) 443–5926.

Agenda Items are subject to change as

priorities dictate.

Dated: September 29, 1997.

Jane M. Harrison,

Acting Director, Division of Policy Review

and Coordination, HRSA.

[FR Doc. 97–26288 Filed 10–2–97; 8:45 am]

BILLING CODE 4160–15–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Substance Abuse and Mental Health

Services Administration

Current List of Laboratories Which

Meet Minimum Standards To Engage in

Urine Drug Testing for Federal

Agencies, and Laboratories That Have

Withdrawn From the Program

AGENCY: Substance Abuse and Mental

Health Services Administration, HHS

(Formerly: National Institute on Drug

Abuse, ADAMHA, HHS).

ACTION: Notice.

SUMMARY: The Department of Health and

Human Services notifies Federal

agencies of the laboratories currently

certified to meet standards of Subpart C

of Mandatory Guidelines for Federal

Workplace Drug Testing Programs (59

FR 29916, 29925). A similar notice

listing all currently certified laboratories

will be published during the first week

of each month, and updated to include

laboratories which subsequently apply

for and complete the certification

process. If any listed laboratory’s

certification is totally suspended or

revoked, the laboratory will be omitted

from updated lists until such time as it

is restored to full certification under the

Guidelines.

If any laboratory has withdrawn from

the National Laboratory Certification

Program during the past month, it will

be identified as such at the end of the

current list of certified laboratories, and

will be omitted from the monthly listing

thereafter.

This Notice is now available on the

internet at the following website:

http://www.health.org

FOR FURTHER INFORMATION CONTACT: Mrs.

Giselle Hersh or Dr. Walter Vogl,

Division of Workplace Programs, Room

13A–54, 5600 Fishers Lane, Rockville,

Maryland 20857; Tel.: (301) 443–6014.

SUPPLEMENTARY INFORMATION:

Mandatory Guidelines for Federal

Workplace Drug Testing were developed

in accordance with Executive Order

12564 and section 503 of Public Law

100–71. Subpart C of the Guidelines,

‘‘Certification of Laboratories Engaged

in Urine Drug Testing for Federal

Agencies,’’ sets strict standards which

laboratories must meet in order to

conduct urine drug testing for Federal

agencies. To become certified an

applicant laboratory must undergo three

rounds of performance testing plus an

on-site inspection. To maintain that

certification a laboratory must

participate in a quarterly performance
51876 Federal Register / Vol. 62, No. 192 / Friday, October 3, 1997 / Notices

testing program plus periodic, on-site

inspections.

Laboratories which claim to be in the

applicant stage of certification are not to

be considered as meeting the minimum

requirements expressed in the HHS

Guidelines. A laboratory must have its

letter of certification from SAMHSA,

HHS (formerly: HHS/NIDA) which

attests that it has met minimum

standards.

In accordance with Subpart C of the

Guidelines, the following laboratories

meet the minimum standards set forth

in the Guidelines:

ACL Laboratory, 8901 W. Lincoln Ave.,

West Allis, WI 53227, 414–328–7840,

(formerly: Bayshore Clinical

Laboratory)

Aegis Analytical Laboratories, Inc., 345

Hill Ave., Nashville, TN 37210, 615–

255–2400

Alabama Reference Laboratories, Inc.,

543 South Hull St., Montgomery, AL

36103, 800–541–4931 / 334–263–5745

American Medical Laboratories, Inc.,

14225 Newbrook Dr., Chantilly, VA

22021, 703–802–6900

Associated Pathologists Laboratories,

Inc., 4230 South Burnham Ave., Suite

250, Las Vegas, NV 89119–5412,

702–733–7866 / 800–433–2750

Associated Regional and University,

Pathologists, Inc. (ARUP) 500 Chipeta

Way, Salt Lake City, UT 84108,

801–583–2787 / 800–242–2787

Baptist Medical Center—Toxicology,

Laboratory 9601 I–630, Exit 7, Little

Rock, AR 72205–7299, 501–202–2783,

(formerly: Forensic Toxicology

Laboratory Baptist Medical Center)

Cedars Medical Center, Department of

Pathology, 1400 Northwest 12th Ave.,

Miami, FL 33136, 305–325–5784

Centinela Hospital Airport Toxicology

Laboratory, 9601 S. Sepulveda Blvd.,

Los Angeles, CA 90045, 310–215–

6020

Clinical Reference Lab, 8433 Quivira

Rd., Lenexa, KS 66215–2802, 800–

445–6917

CompuChem Laboratories, Inc., 1904

Alexander Drive, Research Triangle

Park, NC 27709, 919–572–6900/800–

833–3984, (Formerly: CompuChem

Laboratories, Inc., A Subsidiary of

Roche Biomedical Laboratory, Roche

CompuChem Laboratories, Inc., A

Member of the Roche Group)

Cox Health Systems, Department of

Toxicology, 1423 North Jefferson

Ave., Springfield, MO 65802, 800–

876–3652/417–269–3093, (formerly:

Cox Medical Centers)

Dept. of the Navy, Navy Drug Screening

Laboratory, Great Lakes, IL, P.O. Box

88–6819, Great Lakes, IL 60088–6819,

847–688–2045/847–688–4171

Diagnostic Services Inc., dba DSI, 4048

Evans Ave., Suite 301, Fort Myers, FL

33901, 941–418–1700/800–735–5416

Doctors Laboratory, Inc., P.O. Box 2658,

2906 Julia Dr., Valdosta, GA 31604,

912–244–4468

DrugProof, Division of Dynacare/

Laboratory of Pathology, LLC, 1229

Madison St., Suite 500, Nordstrom

Medical Tower, Seattle, WA 98104,

800–898–0180/206–386–2672,

(formerly: Laboratory of Pathology of

Seattle, Inc., DrugProof, Division of

Laboratory of Pathology of Seattle,

Inc.)

DrugScan, Inc., P.O. Box 2969, 1119

Mearns Rd., Warminster, PA 18974,

215–674–9310

ElSohly Laboratories, Inc., 5 Industrial

Park Dr., Oxford, MS 38655, 601–236–

2609

General Medical Laboratories 36 South

Brooks St., Madison, WI 53715, 608–

267–6267

Harrison Laboratories, Inc., 9930 W.

Highway 80, Midland, TX 79706,

800–725–3784/915–563–3300,

(formerly: Harrison & Associates

Forensic, Laboratories),

Jewish Hospital of Cincinnati, Inc., 3200

Burnet Ave., Cincinnati, OH 45229,

513–569–2051

LabOne, Inc., 8915 Lenexa Dr., Overland

Park, Kansas 66214, 913–888–3927/

800–728–4064, (formerly: Center for

Laboratory Services, a Division of

LabOne, Inc.)

Laboratory Corporation of America, 888

Willow St., Reno, NV 89502, 702–

334–3400, (formerly: Sierra Nevada

Laboratories, Inc.)

Laboratory Corporation of America

Holdings, 69 First Ave., Raritan, NJ

08869, 800–437–4986/908–526–2400,

(Formerly: Roche Biomedical

Laboratories, Inc.)

Laboratory Specialists, Inc., 1111

Newton St., Gretna, LA 70053, 504–

361–8989/800–433–3823

Marshfield Laboratories, Forensic

Toxicology Laboratory, 1000 North

Oak Ave., Marshfield, WI 54449, 715–

389–3734/800–331–3734

MedExpress/National Laboratory

Center, 4022 Willow Lake Blvd.,

Memphis, TN 38118, 901–795–1515/

800–526–6339

Medical College Hospitals Toxicology

Laboratory, Department of Pathology,

3000 Arlington Ave., Toledo, OH

43614, 419–381–5213

Medlab Clinical Testing, Inc., 212

Cherry Lane, New Castle, DE 19720,

302–655–5227

MedTox Laboratories, Inc., 402 W.

County Rd. D, St. Paul, MN 55112,

800–832–3244/612–636–7466

Methodist Hospital Toxicology Services

of Clarian Health Partners, Inc.,

Department of Pathology and

Laboratory Medicine, 1701 N. Senate

Blvd., Indianapolis, IN 46202, 317–

929–3587

Methodist Medical Center Toxicology

Laboratory, 221 N.E. Glen Oak Ave.,

Peoria, IL 61636, 800–752–1835/309–

671–5199

MetroLab-Legacy Laboratory Services,

235 N. Graham St., Portland, OR

97227, 503–413–4512, 800–237–7808

(x4512)

Minneapolis Veterans Affairs Medical

Center, Forensic Toxicology

Laboratory, 1 Veterans Drive,

Minneapolis, Minnesota 55417, 612–

725–2088

National Toxicology Laboratories, Inc.,

1100 California Ave., Bakersfield, CA

93304, 805–322–4250

Northwest Toxicology, Inc., 1141 E.

3900 South, Salt Lake City, UT 84124,

800–322–3361/801–268–2431

Oregon Medical Laboratories, P.O. Box

972, 722 East 11th Ave., Eugene, OR

97440–0972, 541–341–8092

Pathology Associates Medical

Laboratories, 11604 E. Indiana,

Spokane, WA 99206, 509–926–2400/

800–541–7891

PharmChem Laboratories, Inc., 1505–A

O’Brien Dr., Menlo Park, CA 94025,

415–328–6200/800–446–5177

PharmChem Laboratories, Inc., Texas

Division, 7606 Pebble Dr., Fort Worth,

TX 76118, 817–595–0294, (formerly:

Harris Medical Laboratory)

Physicians Reference Laboratory, 7800

West 110th St., Overland Park, KS

66210, 913–339–0372/800–821–3627

Poisonlab, Inc., 7272 Clairemont Mesa

Blvd., San Diego, CA 92111, 619–279–

2600/800–882–7272

Premier Analytical Laboratories, 15201

East I–10 Freeway, Suite 125,

Channelview, TX 77530, 713–457–

3784/800–888–4063, (formerly: Drug

Labs of Texas)

Presbyterian Laboratory Services, 1851

East Third Street, Charlotte, NC

28204, 800–473–6640

Quest Diagnostics Incorporated, 4444

Giddings Road, Auburn Hills, MI

48326, 810–373–9120/800–444–0106,

(formerly: HealthCare/Preferred

Laboratories, HealthCare/MetPath,

CORNING Clinical Laboratories)

Quest Diagnostics Incorporated,

National Center for Forensic Science,

1901 Sulphur Spring Rd., Baltimore,

MD 21227, 410–536–1485, (formerly:

Maryland Medical Laboratory, Inc.,

National Center for Forensic Science,

CORNING National Center for

Forensic Science)

Quest Diagnostics Incorporated, 4770

Regent Blvd., Irving, TX 75063, 800–

526–0947/972–916–3376, (formerly:

Damon Clinical Laboratories, Damon/
Federal Register / Vol. 62, No. 192 / Friday, October 3, 1997 / Notices 51877

MetPath, CORNING Clinical

Laboratories)

Quest Diagnostics Incorporated, 875

Greentree Rd., 4 Parkway Ctr.,

Pittsburgh, PA 15220–3610, 800–574–

2474/412–920–7733, (formerly: MedChek Laboratories, Inc., Med-Chek/

Damon, MetPath Laboratories,

CORNING Clinical Laboratories)

Quest Diagnostics Incorporated, 2320

Schuetz Rd., St. Louis, MO 63146,

800–288–7293/314–991–1311,

(formerly: Metropolitan Reference

Laboratories, Inc., CORNING Clinical

Laboratories, South Central Division)

Quest Diagnostics Incorporated, 7470

Mission Valley Rd., San Diego, CA

92108–4406, 800–446–4728/619–686–

3200, (formerly: Nichols Institute,

Nichols Institute Substance Abuse

Testing (NISAT), CORNING Nichols

Institute, CORNING Clinical

Laboratories)

Quest Diagnostics Incorporated, One

Malcolm Ave., Teterboro, NJ 07608,

201–393–5590, (formerly: MetPath,

Inc., CORNING MetPath Clinical

Laboratories, CORNING Clinical

Laboratory)

Quest Diagnostics Incorporated, 1355

Mittel Blvd. Wood Dale, IL 60191,

630–595–3888, (formerly: MetPath,

Inc., CORNING MetPath Clinical

Laboratories, CORNING Clinical

Laboratories Inc.)

Scientific Testing Laboratories, Inc. 463

Southlake Blvd., Richmond, VA

23236, 804–378–9130

Scott & White Drug Testing Laboratory,

600 S. 25th St., Temple, TX 76504,

800–749–3788/254–771–8379

S.E.D. Medical Laboratories, 500 Walter

NE, Suite 500, Albuquerque, NM

87102, 505–727–8800/800–999–LABS

SmithKline Beecham Clinical

Laboratories, 3175 Presidential Dr.,

Atlanta, GA 30340, 770–452–1590,

(formerly: SmithKline Bio-Science

Laboratories)

SmithKline Beecham Clinical

Laboratories, 8000 Sovereign Row,

Dallas, TX 75247, 214–637–7236,

(formerly: SmithKline Bio-Science

Laboratories)

SmithKline Beecham Clinical

Laboratories, 801 East Dixie Ave.,

Leesburg, FL 34748, 352–787–9006,

(formerly: Doctors & Physicians

Laboratory)

SmithKline Beecham Clinical

Laboratories, 400 Egypt Rd.,

Norristown, PA 19403, 800–877–

7484/610–631–4600, (formerly:

SmithKline Bio-Science Laboratories)

SmithKline Beecham Clinical

Laboratories, 506 E. State Pkwy.,

Schaumburg, IL 60173, 847–447–

4379/800–447–4379, (formerly:

International Toxicology Laboratories)

SmithKline Beecham Clinical

Laboratories, 7600 Tyrone Ave., Van

Nuys, CA 91405, 818–989–2520/800–

877–2520

South Bend Medical Foundation, Inc.,

530 N. Lafayette Blvd., South Bend,

IN 46601, 219–234–4176

Southwest Laboratories, 2727 W.

Baseline Rd., Tempe, AZ 85283, 602–

438–8507

St. Anthony Hospital Toxicology

Laboratory, P.O. Box 205, 1000 N. Lee

St., Oklahoma City, OK 73101, 405–

272–7052

Toxicology & Drug Monitoring

Laboratory, University of Missouri

Hospital & Clinics, 2703 Clark Lane,

Suite B, Lower Level, Columbia, MO

65202, 573–882–1273

Toxicology Testing Service, Inc., 5426

N.W. 79th Ave., Miami, FL 33166,

305–593–2260

TOXWORX Laboratories, Inc., 6160

Variel Ave., Woodland Hills, CA

91367, 818–226–4373/800–966–2211,

(formerly: Laboratory Specialists, Inc.;

Abused Drug Laboratories; MedTox

Bio-Analytical, a Division of MedTox

Laboratories, Inc.)

UNILAB, 18408 Oxnard St., Tarzana,

CA 91356, 800–492–0800/818–996–

7300, (formerly: MetWest-BPL

Toxicology Laboratory)

Universal Toxicology Laboratories, LLC,

10210 W. Highway 80, Midland,

Texas 79706, 915–561–8851/888–

953–8851

UTMB Pathology-Toxicology

Laboratory, University of Texas

Medical Branch, Clinical Chemistry

Division, 301 University Boulevard,

Room 5.158, Old John Sealy,

Galveston, Texas 77555–0551, 409–

772–3197

The Standards Council of Canada

(SCC) Laboratory Accreditation Program

for Substances of Abuse (LAPSA) has

been given deemed status by the

Department of Transportation. The SCC

has accredited the following Canadian

laboratory for the conduct of forensic

urine drug testing required by

Department of Transportation

regulations: MAXXAM Analytics Inc.,

5540 McAdam Rd., Mississauga, ON,

Canada L4Z 1P1, 905–890–2555,

(formerly: NOVAMANN (Ontario) Inc.)

Richard Kopanda,

Executive Officer, Substance Abuse and

Mental Health Services Administration.

[FR Doc. 97–26356 Filed 10–2–97; 8:45 am]

BILLING CODE 4160–20–U

DEPARTMENT OF HOUSING AND

URBAN DEVELOPMENT

[Docket No. FR–4263–N–31]

Office of Lead Hazard Control; Notice

of Proposed Information Collection:

Comment Request

AGENCY: Office of Lead Hazard Control,

HUD.

ACTION: Notice.

SUMMARY: The proposed information

collection requirement described below

will be submitted to the Office of

Management and Budget (OMB) for

review, as required by the Paperwork

Reduction Act. The Department is

soliciting public comments on the

subject proposal.

DATES: Comments due: December 2,

1997.

ADDRESSES: Interested persons are

invited to submit comments regarding

this proposal. Comments should refer to

the proposal by name and/or OMB

Control Number and should be sent to:

Ms. Ruth Wright, Reports Liaison

Officer, Office of Lead Hazard Control

(L), Department of Housing and Urban

Development, 451–7th Street, SW,

Room B–133, Washington, DC 20410.

FOR FURTHER INFORMATION CONTACT:

Dr. Warren Friedman at (202) 755–1785,

extension 159 (this is not a toll-free

number), Office of Lead Hazard Control,

HUD, for copies of the proposed forms

and other available documents.

SUPPLEMENTARY INFORMATION: The

Department will submit the proposed

information collection to OMB for

review, as required by the Paperwork

Reduction Act of 1995 (44 U.S.C.

Chapter 35, as amended).

The notice is soliciting comments

from members of the public and

affecting agencies concerning the

proposed collection of information to:

(1) Evaluate whether the proposed

collection of information is necessary

for the proper performance of the

functions of the agency, including

whether the information will have

practical utility;

(2) Evaluate the accuracy of the

agency’s estimate of the burden of the

proposed collection of information;

(3) Enhance the quality, utility, and

clarity of the information to be

collected; and

(4) Minimize the burden of the

collection of information on those who

are to respond; including through the

use of appropriate automated collection

techniques or other forms of information

technology, e.g., permitting electronic

submission of responses.

This Notice also lists the following

information: